FLGT FY 2023 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

FY 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$289M-53.3% YoY

Gross Profit

$104M36.1% margin

Operating Income

-$196M-67.6% margin

Net Income

-$168M-58.0% margin

EPS (Diluted)

$-5.63

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$5M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$102M

Stockholders' Equity

$1.1B

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$289M	$619M	-53.3%
Gross Profit	$104M	$367M	-71.5%
Operating Income	-$196M	$179M	-209.5%
Net Income	-$168M	$143M	-217.0%